Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8081
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agents, biological ingredients and inducers and adjuvant for biological development. Sirona Biochem offers products such as sodium glucose transporter inhibitors, cancer antigen, skin brightener, depigmenting agent, anti-aging cosmetic ingredients, inducers and adjuvant, among others. The company offers TFchem for annalogs of existing glycoconjugates, neo-glycosylation of active molecular, new chemical entities, and others. The company operates in Canada, France, and others. Sirona Biochem is headquartered in Vancouver, British Columbia, Canada.

Sirona Biochem Corp (SBM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sirona Biochem Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sirona Biochem Corp, Medical Devices Deals, 2012 to YTD 2018 10
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Sirona Biochem Enters Into Licensing Agreement With Cincinnati Children’s Hospital Medical Center 13
Sirona Biochem Enters into Research Agreement with University of British Columbia 14
Sirona Biochem Enters Into Joint Venture Agreement With Bloom Burton 15
Sirona Biochem Enters Into Agreement With Cincinnati Children’s Hospital To Create Novel Skin Care Technology 16
Licensing Agreements 17
Sirona Biochem Expands Licensing Agreement with Valeant Pharma 17
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 18
Sirona Biochem Enters into Licensing Agreement with Wanbang Biopharma for SGLT2 Inhibitor 19
Equity Offering 21
Sirona Biochem Raises USD0.53 Million in Equity Offering of Units 21
Sirona Biochem Raises USD0.4 Million in Private Placement of Shares 22
Sirona Biochem Raises USD0.6 Million in Private Placement of Units 23
Sirona Biochem Raises USD0.8 Million in Private Placement of Shares up on Exercise of Warrants 24
Sirona Biochem Raises USD0.94 Million in Private Placement of Shares upon Exercise of Warrants 25
Sirona Biochem Completes Private Placement Of Shares For US$1 Million 26
Sirona Biochem Announces Private Placement Of Units For US$5 Million 27
Sirona Biochem Completes Private Placement Of Units For US$1 Million 28
Sirona Biochem Completes Second Tranche Of Private Placement Of Units For US$0.38 Million 29
Sirona Biochem Completes Private Placement Of Units For US$1.41 Million 30
Debt Offering 31
Sirona Biochem Raises USD0.43 Million in Private Placement of Convertible Notes 31
Sirona Biochem Raises USD0.5 Million in Private Placement of Convertible Notes Due 2018 32
Sirona Biochem Corp – Key Competitors 33
Sirona Biochem Corp – Key Employees 34
Sirona Biochem Corp – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Corporate Communications 36
Oct 30, 2017: Sirona Announces Resignation of Board Director 36
Sep 13, 2017: Sirona Biochem Announces Resignation of Board Director 37
Feb 16, 2017: Sirona Biochem Announces Management Changes 38
Product News 39
Jan 31, 2018: Sirona Biochem Announces Development of Anti-Wrinkle Treatment and Update from J.P. Morgan Healthcare Conference 39
Product Approvals 40
Jan 29, 2018: Sirona Biochem Announces Receipt of $500,000 US Milestone Payment 40
Dec 29, 2017: Sirona Biochem Announces SGLT2 IND Submission Milestone 41
Clinical Trials 42
Aug 28, 2018: Sirona Biochem receives $500,000 USD milestone payment from Wanbang Biopharmaceuticals 42
Jul 12, 2018: Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial 43
Other Significant Developments 44
Dec 19, 2017: Sirona Biochem Announces Results of AGM & CEO Update 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sirona Biochem Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sirona Biochem Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Sirona Biochem Corp, Medical Devices Deals, 2012 to YTD 2018 10
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sirona Biochem Enters Into Licensing Agreement With Cincinnati Children's Hospital Medical Center 13
Sirona Biochem Enters into Research Agreement with University of British Columbia 14
Sirona Biochem Enters Into Joint Venture Agreement With Bloom Burton 15
Sirona Biochem Enters Into Agreement With Cincinnati Children's Hospital To Create Novel Skin Care Technology 16
Sirona Biochem Expands Licensing Agreement with Valeant Pharma 17
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 18
Sirona Biochem Enters into Licensing Agreement with Wanbang Biopharma for SGLT2 Inhibitor 19
Sirona Biochem Raises USD0.53 Million in Equity Offering of Units 21
Sirona Biochem Raises USD0.4 Million in Private Placement of Shares 22
Sirona Biochem Raises USD0.6 Million in Private Placement of Units 23
Sirona Biochem Raises USD0.8 Million in Private Placement of Shares up on Exercise of Warrants 24
Sirona Biochem Raises USD0.94 Million in Private Placement of Shares upon Exercise of Warrants 25
Sirona Biochem Completes Private Placement Of Shares For US$1 Million 26
Sirona Biochem Announces Private Placement Of Units For US$5 Million 27
Sirona Biochem Completes Private Placement Of Units For US$1 Million 28
Sirona Biochem Completes Second Tranche Of Private Placement Of Units For US$0.38 Million 29
Sirona Biochem Completes Private Placement Of Units For US$1.41 Million 30
Sirona Biochem Raises USD0.43 Million in Private Placement of Convertible Notes 31
Sirona Biochem Raises USD0.5 Million in Private Placement of Convertible Notes Due 2018 32
Sirona Biochem Corp, Key Competitors 33
Sirona Biochem Corp, Key Employees 34
Sirona Biochem Corp, Subsidiaries 35

List of Figures
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sirona Biochem Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Spark Infrastructure Group (SKI):企業の財務・戦略的SWOT分析
    Spark Infrastructure Group (SKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sysmex America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex America Inc (Sysmex America), a subsidiary of Sysmex Corp is a medical device company that manufactures laboratory testing equipments. The company's products include clinical diagnostic devices, in vitro diagnostic hematology devices, urinalysis devices, reagents and information syste …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • Murphy Oil Corp (MUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company operates oil and gas fields in the US, Canada, Malaysia, Australia, Brunei, Vietnam and Mexico. M …
  • Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務分析
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Advanced Enzyme Technologies Ltd:企業の戦略・SWOT・財務情報
    Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Santee Cooper:企業の戦略的SWOT分析
    Santee Cooper - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務情報
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Biocodex-製薬・医療分野:企業M&A・提携分析
    Summary Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an …
  • Tangent Energy Solutions, Inc.:企業の戦略的SWOT分析
    Tangent Energy Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Mapletree Commercial Trust Management Ltd:企業の戦略・SWOT・財務情報
    Mapletree Commercial Trust Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Mapletree Commercial Trust Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Dana Inc:企業の戦略・SWOT・財務情報
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Grupo Juste SAQF-製薬・医療分野:企業M&A・提携分析
    Summary Grupo Juste SAQF (Juste) discovers, develops and distributes pharmaceutical products and active pharmaceutical ingredients (APIs). It develops and manufactures oral and injectable radiological contrast media; antidepressants, oral contraceptives, prebiotic formulations for the prevention of …
  • Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆